Scientists may have discovered the first antidote to the deadliest mushroom known to humans

by | May 21, 2023 | Science

Death cap mushrooms kill more humans each year than any other poisonous mushroom.WILLIAM WEST / Contributor / Getty ImagesDeath cap mushrooms kill up to 100 people per year and sicken thousands more but have no antidote.Scientists used CRISPR to help identify a chemical that could become the first death cap antidote.Half of mice poisoned with the death cap’s toxin survived after the new treatment.The death cap is the deadliest mushroom known to humans. Each year, it kills an estimated 100 people and sickens thousands more.Many of its victims are unsuspecting foragers who mistake it for the edible fungi it resembles, like puffballs and paddy-straws.There is no antidote to the mushroom’s deadly toxin. The only way to survive if you mistakenly eat one — even downing just half a cap could shut down your liver — is a trip to the ER.But that may change soon enough.A recent study in Nature Communications finally found a possible death cap mushroom antidote. The researchers report that an FDA-approved compound known as indocyanine green (ICG) can inhibit the mushroom’s deadly toxin.A death cap mushroom antidote is long-awaitedMushroom foragers can easily mistake death cap mushrooms for other edible fungi.Carlina Teteris/Getty ImagesScientists have been studying death cap mushrooms since the early 1700s but an antidote has largely eluded them because “we know little about how mushroom toxins kill cells,” Qiaoping Wang, a professor of pharmacology at Sun Yat-Sen University and one of the study’s lead authors, told Insider.Many toxins like cyanide, botulinum toxin, and asbestos can be destroyed or denatured by heating, drying, cooling, or boiling them. But none of these methods work on the death cap’s toxin, alpha-amanitin.To identify a potential antidote, Wang and his colleagues turned to the gene-editing tool CRISPR. They screened thousands of human genes and discovered that a promising type of enzyme called STT3B. In particular, cells that lacked this STT3B survived when the scientists poisoned them with alpha-amanitin.But deactivating STT3B in cells with CRISPR isn’t something you can just do in a hospital on a poisoned, dying patient. To identify a possible antidote for death cap victims, the researchers took the additional step to test various chemicals and their affect on STT3B.Story continuesThey found a promising candidate in the chemical indocyanine green. “ICG is a potential STT3B inhibitor that can prevent AMA-induced cell death,” they reported in the study.Will the antidote work for humans?Researchers plan to test the ICG antidote on poisoned human subjects next but when that will happen is u …

Article Attribution | Read More at Article Source

Share This